IP Library Assignment 061824/0877
Patent Assignment
Reel/Frame 061824/0877

Change of Name

Recorded: 2022-10-31 Pages: 5
Assignor
SILK THERAPEUTICS, INC.
Executed: 2018-04-24
Assignee
SILK, INC.
200 BOSTON AVENUE, MEDFORD, MASSACHUSETTS, 02155
Covered Properties (7)
Stable Silk Protein Fragment Compositions
Application: 17/716,730 →
Publication: US 2023/0085841
Stable Silk Protein Fragment Compositions
Application: 17/716,743 →
Publication: US 2022/0226223
Silk Protein Fragment Compositions and Articles Manufactured Therefrom
Application: 17/861,936 →
Publication: US 2023/0212234
Stable Silk Fibroin Based Pharmaceutical Formulations
Application: 16/453,597 →
Publication: US 2019/0380944
Stable Silk Fibroin Based Pharmaceutical Formulations
Application: 16/453,620 →
Publication: US 2019/0336431
Stable Silk Protein Fragment Compositions
Application: 16/795,488 →
Publication: US 2020/0188268
Stable Silk Protein Fragment Compositions
Application: 16/795,921 →
Publication: US 2020/0188269
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 31, 2022
From: ALTMAN, GREGORY H.; HORAN, REBECCA L.; DOW, RACHEL LEE; LIND, RACHEL M.
To: SILK THERAPEUTICS, INC.
Reel/Frame 061602/0219 →
Change of Name Oct 31, 2022
From: SILK, INC.
To: EVOLVED BY NATURE, INC.
Reel/Frame 061824/0908 →